Effects of short-term pregnancy hormone treatment against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats

In Vivo

Volumn 25, Issue 2, 2011, Pages 149-156

  Lai, Yen Chang ^a   Katsuhiko, Yoshizawa ^a   Kimura Kawanaka, Ayako ^a   Miki, Hisanori ^a   Sasaki, Tomo ^a   Tsubura, Airo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Estradiol; Mammary cancer; N methyl N nitrosourea; Perphenazine; Progesterone; Prolactin; Rat

Indexed keywords

ESTRADIOL; METHYLNITROSOUREA; PERPHENAZINE; PROGESTERONE; PROLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER HORMONE THERAPY; CONTROLLED STUDY; FEMALE; HISTOLOGY; LEWIS RAT; NONHUMAN; RAT;

EID: 79954990010     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Coughlin SS and Ekwueme DU: Breast cancer as a global health concern. Cancer Epidemiol 33: 315-318, 2009.
2. Mustacchi P: Ramazzini and Rigoni-Stern on parity and breast cancer. Clinical impression and statistical corroboration. Arch Intern Med 108: 639-642, 1961.
3. MacMahon B, Cole P and Brown J: Etiology of human breast cancer: a review. J Natl Cancer Inst 50: 21-42, 1973.
4. Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG and Yuasa S: Age at any birth and breast cancer risk. Int J Cancer 31: 701-704, 1983. (Pubitemid 13060771)
5. Nagata C, Hu YH and Shimizu H: Effects of menstrual and reproductive factors on the risk of breast cancer: meta-analysis of the case control studies in Japan. Jpn J Cancer Res 86: 910-915, 1995.
6. Chie WC, Hsieh C, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP Titus-Ernstoff L, Trentham-Dietz A and MacMahon B: Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151: 715-722, 2000. (Pubitemid 30463593)
7. Lipworth L, Bailey LR and Trichopoulos D: History of breastfeeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst 92: 302-312, 2000. (Pubitemid 30117733)
8. Schedin P: Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 6: 281-291, 2006.
9. Yang J, Yoshizawa K, Nandi S and Tsubura A: Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. Carcinogenesis 20: 623-628, 1999. (Pubitemid 29151298)
10. Nandi S, Guzman RC, Thordarson G and Rajkumar L: Estrogen can prevent breast cancer by mimicking the protective effect of pregnancy. In: Hormonal Carcinogenesis IV. Li JJ, Li SA and Llombart-Bosch A (eds.) New York: Springer, pp. 165-179, 2005.
11. Tsubura A, Uehara N, Matsuoka Y, Yoshizawa K and Yuri T: Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer. In Vivo 22: 191-202, 2008. (Pubitemid 351523556)
12. Grubbs CJ, Hill DL, McDonough KC and Peckham JC: N-Nitroso-N-methylurea- induced mammary carcinogenesis: effect of pregnancy on preneoplastic cells. J Natl Cancer Inst 71: 625-628, 1983.
13. Grubbs CJ, Juliana MM, Hill DL and Whitaker LM: Suppression by pregnancy of chemically induced preneoplastic cells of the rat mammary gland. Anticancer Res 6: 1395-1400, 1986.
14. Marchetti B, Fortier MA, Poyet P, Folléa N, Pelletier G and Labrie F: Beta-adrenergic receptors in the rat mammary gland during pregnancy and lactation: characterization, distribution, and coupling to adenylate cyclase. Endocrinology 126: 565-574, 1990. (Pubitemid 20037190)
15. Thordarson G, Van Horn K, Guzman RC, Nandi S and Talamantes F: Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones. Carcinogenesis 22: 1027-1033, 2001. (Pubitemid 32633600)
16. Yuri T, Tsukamoto R, Uehara N, Matsuoka Y and Tsubura A: Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. In Vivo 20: 829-836, 2006. (Pubitemid 46061586)
17. Rajkumar L, Arumugam A, Elsayed A, Schecter S, Kotkowski E, Castillo R, de la Torre A and Hernandez C: Long-term hormonal promotion overcomes genetic resistance to mammary cancer. Steroids 76: 31-37, 2011.
18. Huggins C, Moon RC and Morii S: Extinction of experimental mammary cancer. I. Estradiol-17beta and progesterone. Proc Natl Acad Sci USA 48: 379-386, 1962.
19. Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X and Nandi S: Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 96: 2520-2525, 1999.
20. Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F and Nandi S: Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci USA 98: 11755-11759, 2001. (Pubitemid 32928801)
21. Harvey PW, Everett DJ and Springall CJ: Adverse effects of prolactin in rodents and humans: breast and prostate cancer. J Psychopharmacol 22(2 Suppl): 20-27, 2008.
22. Russo J and Russo IH: Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 5: 187-200, 2000. (Pubitemid 32045695)
23. Swanson SM, Whitaker LM, Stockard CR, Myers RB, Oelschlager D, Grizzle WE, Juliana MM and Grubbs CJ: Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer. Anticancer Res 17: 4639-4645, 1997. (Pubitemid 28081758)
24. Tsukamoto R, Mikami T, Miki K, Uehara N, Yuri T, Matsuoka Y, Okazaki K and Tsubura A: N-Methyl-N-nitrosourea-induced mammary carcinogenesis is promoted by short-term treatment with estrogen and progesterone mimicking pregnancy in aged female Lewis rats. Oncol Rep 18: 337-342, 2007.
25. Lai Y-C, Yuri T, Uehara N, Matsuoka Y, Kanematsu S and Tsubura A: Biphasic effect of short-term pregnancy hormone treatment on N-methyl-N-nitrosourea-induced mammary carcinogenesis in young and old rats. Mol Med Rep 2: 213-220, 2009.
26. Yoshida H, Yoshida A, Yamada M, Yamanaka K, Kitamura Y and Matsumoto K: Regression with secretory changes of ovary-independent rat mammary carcinoma by pharmacological doses of estrogen. Jpn J Cancer Res 76: 771-778, 1985. (Pubitemid 15232462)
27. Shigaki N, Kimura M, Takano S, Fujino N and Akagi M: Reduction of estrogen and prolactin receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor by high doses of estrogen. Jpn J Surg 17: 395-401, 1987. (Pubitemid 18056049)
28. Wang PS, Walker AM, Tsuang MT, Orav EJ, Glynn RJ, Levin R and Avorn J: Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry 59: 1147-1154, 2002. (Pubitemid 35424025)
29. Muller E and Dowling RH: Prolactin and the small intestine. Effect of hyperprolactinaemia on mucosal structure in the rat. Gut 22: 558-565, 1981.
30. Tokunaga M, Land CE, Yamamoto T, Asano M, Tokuoka S, Ezaki H and Nishimori I: Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat Res 112: 243-272, 1987.
31. Shoyab M: Enhancement by fluphenazine of dimethylbenz[α]- anthracene-induced mammary tumorigenesis in rats. Cancer Lett 18: 297-303, 1983.
32. Tsubura A, Hatano T, Murata A, Shoji T, Shikata N and Morii S: Breast carcinoma in patients receiving neuroleptic therapy. Morphologic and clinicopathologic features of thirteen cases. Acta Pathol Jpn 42: 494-499, 1992.
33. Hilf R, Michel I and Bell C: Biochemical and morphological responses of normal and neoplastic mammary tissue to hormonal treatment. Recent Prog Horm Res 23: 229-295, 1967.
34. Shiu RP and Paterson JA: Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone. Cancer Res 44: 1178-1186, 1984. (Pubitemid 14151524)
35. Swanson SM, Guzman RC, Collins G, Tafoya P, Thordarson G, Talamantes F and Nandi S: Refractoriness to mammary carcinogenesis in the parous mouse is reversible by hormonal stimulation induced by pituitary isografts. Cancer Lett 90: 171-181, 1995.
36. Lyons TR, Schedin PJ and Borges VF: Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 14: 87-98, 2009.
37. Uehara N, Unami A, Kiyozuka Y, Shikata N, Oishi Y and Tsubura A: Parous mammary glands exhibit distinct alterations in gene expression and proliferation responsiveness to carcinogenic stimuli in Lewis rats. Oncol Rep 15: 903-911, 2006.
38. Matsuoka Y, Fukamachi K, Uehara N, Tsuda H and Tsubura A: Induction of a novel histone deacetylase 1/c-Myc/Mnt/Max complex formation is implicated in parity-induced refractoriness to mammary carcinogenesis. Cancer Sci 99: 309-315, 2008. (Pubitemid 351228485)
39. Tsubura A, Yuri T, Yoshizawa K, Uehara N and Takada H: Role of fatty acids in malignancy and visual impairment: epidemiological evidence and experimental studies. Histol Histopathol 24: 223-234, 2009.
40. Lai Y-C, Hamazaki K, Yoshizawa K, Kawanaka A, Kuwata M, Kanematsu S, Hamazaki T, Takada H and Tsubura A: Short-term pregnancy hormone treatment on N-methyl-N-nitrosourea-induced mammary carcinogenesis in relation to fatty acid composition of serum phospholipids in female Lewis rats. In Vivo 24: 553-560, 2010.